United States· US:16571-174_9fdff54f-c6fc-4215-a611-5051a7fbae84

Eplerenone

A eplerenone product containing eplerenone, registered in United States by Rising Pharma Holdings, Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC C03DA04US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about eplerenoneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Eplerenone is registered in 17 of 19 countries.

Countries holding a registration under ATC C03DA04 (eplerenone), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
10 of them publish a price we can compare per daily dose

Search eplerenone products by name

Eplerenone · ATC C03DA04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eplerenone costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.05 in France to $3.72 in Switzerland — a ×3.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Eplerenone · price per daily dose (50 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.72
IT Italy$1.47
FR France$1.05

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: EPLERENONE
Manufacturer: Rising Pharma Holdings, Inc.
Country: United States (US)
ATC code: C03DA04
ATC class: Eplerenone
Defined daily dose: 50 mg, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 4

ndc11
1657117403
30 TABLET in 1 BOTTLE (16571-174-03)
ndc11
1657117409
90 TABLET in 1 BOTTLE (16571-174-09)
ndc11
16571-174-03
ndc11
16571-174-09

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

230 interactions on record for eplerenone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check eplerenone against other medicines How interaction checks work

Eplerenone · interactions on record

230 records

32 severe
97 moderate
3 minor
24 info

Most severe, free to view

ClotrimazoleA01AB18severe
AprepitantA04AD12severe
Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe

74 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eplerenone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplerenone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Eplerenon +pharma, Eplerenon Actavis
Belgium · Eplerenone Ab, Inspra
Bulgaria · Eспиро, Аплериа
Cyprus · Apleria, Eplerenone Accord
Czechia · Apleria, Eplerenon Medreg
Germany · Epleraxiro, Eplerenon 1 A Pharma
Denmark · Eplerathen, Eplerenon Accord
Estonia · Apleria
Spain · Elecor, Eplerenona Alter
Finland · Inspra
France · Eplerathen, Eplerenone Accord
United Kingdom (Northern Ireland) · Eplerenone, Eplerenone Accord Healthcare
Greece · Apleria, Eleveon
Croatia · Apleria, Diuron
Hungary · Diupot, Eplerenon Krka
Ireland · Eplerenone Accord Healthcare, Eplerenone Krka
Iceland · Eplerenon Bluefish, Eplerenon Krka
Italy · Eplerenone Accord, Eplerenone Doc Generici
Lithuania · Apleria
Luxembourg · Inspra
Latvia · Enplerasa, Plecard
Netherlands · Eplerenon Accord, Eplerenon Amarox
Norway · Eplerenon Accord, Eplerenon Krka
Poland · Eleveon, Enplerasa
Portugal · Eplerenona Biofarmoz, Eplerenona Blovasc
Romania · Apleria, Eplerenonă Arena
Sweden · Eplerenon Accord, Eplerenon Bluefish
Slovenia · Elreptic, Enplerasa
Slovakia · Aldepla, Apleria

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/78470cea-ded5-4e43-a85b-5cac4f5eb580
GET /v1/drugs/78470cea-ded5-4e43-a85b-5cac4f5eb580?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "EPLERENONE",
  "productndc": "16571-174",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA214663",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about eplerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console